Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE6236.4513.1 (+0.21 %)

PREV CLOSE ( ) 6223.35

OPEN PRICE ( ) 6350.00

BID PRICE (QTY) 6241.50 (6)

OFFER PRICE (QTY) 6255.85 (2)

VOLUME 503

TODAY'S LOW / HIGH ( )6198.00 6350.00

52 WK LOW / HIGH ( )2603.2 7794

NSE6239.709.25 (+0.15 %)

PREV CLOSE( ) 6230.45

OPEN PRICE ( ) 6389.95

BID PRICE (QTY) 6237.10 (1)

OFFER PRICE (QTY) 6240.00 (2)

VOLUME 13382

TODAY'S LOW / HIGH( ) 6190.00 6389.95

52 WK LOW / HIGH ( )2603.6 7790

Quarters

Select year

( in Million)

Particulars

Mar 2024

Dec 2023

Sep 2023

Jun 2023

Audited / UnAudited

UnAudited

Net Sales

3850.1

3928.28

4177.49

3629.94

Total Expenditure

2780.94

2715.63

2802.61

2660.73

PBIDT (Excl OI)

1069.16

1212.65

1374.88

969.21

Other Income

53.57

21.01

30.48

20.39

Operating Profit

1122.73

1233.66

1405.35

989.6

Interest

36.09

37.41

44.33

22.14

Exceptional Items

PBDT

1086.64

1196.25

1361.02

967.46

Depreciation

164.63

151.44

145.08

135.86

Profit Before Tax

922.01

1044.81

1215.94

831.6

Tax

246.4

230.91

323.46

212.81

Provisions and contingencies

Profit After Tax

675.61

813.9

892.48

618.79

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

675.61

813.9

892.48

618.79

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

675.62

813.9

892.48

618.79

Equity Capital

129.01

129

129.01

Face Value (IN RS)

Reserves

Calculated EPS

52.36

63.09

69.17

47.96

Calculated EPS (Annualised)

209.47

252.37

276.71

191.85

No of Public Share Holdings

8629725

8621410

8214946

8206857

% of Public Share Holdings

67.26

67.2

64.03

63.97

PBIDTM% (Excl OI)

27.76

30.86

32.91

26.70

PBIDTM%

29.16

31.40

33.64

27.26

PBDTM%

28.22

30.45

32.57

26.65

PBTM%

23.94

26.59

29.10

22.90

PATM%

17.54

20.71

21.36

17.04

Notes

Risk Disclosures on Derivatives

Quarterly Results

NEULAND LABORATORIES LTD.